Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
Authors
Keywords
Cirrhosis, Gene expression, Portal hypertension, Hemodynamics, Protein expression, Fibrosis, Blood pressure, Nitric oxide
Journal
PLoS One
Volume 10, Issue 9, Pages e0138732
Publisher
Public Library of Science (PLoS)
Online
2015-09-26
DOI
10.1371/journal.pone.0138732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- The influence of angiotensin-(1–7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice
- (2013) Maciej Suski et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma
- (2013) M G Rodrigues-Machado et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Angiotensin-(1–7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver
- (2012) Chandana B. Herath et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options
- (2012) Josephine A. Grace et al. CLINICAL SCIENCE
- HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
- (2012) Sabine Klein et al. JOURNAL OF HEPATOLOGY
- Possible mechanism of the cardio-renal protective effects of AVE-0991, a non-peptide Mas-receptor agonist, in diabetic rats
- (2012) Kulwinder Singh et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
- (2012) Lívia Corrêa Barroso et al. International Journal of Hypertension
- AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation
- (2012) Chen Sheng-Long et al. International Journal of Hypertension
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2
- (2009) Chandana B. Herath et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
- (2009) John S. Lubel et al. CLINICAL SCIENCE
- Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis
- (2009) Jonel Trebicka et al. HEPATOLOGY
- Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
- (2008) Montserrat Moreno et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Mechanisms of extrahepatic vasodilation in portal hypertension
- (2008) M Hennenberg et al. GUT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started